Skip to content

Clinical trials

Phase 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1 Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20151
20162
20172
20201
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AbbVie1
AstraZeneca1
Autolus Limited1
Cancer Research UK1
EpiEndo Pharmaceuticals1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Myeloid, Acute4
Recurrence3
Leukemia2
Lymphoma, B-Cell2
Burkitt Lymphoma1
Leukemia, Biphenotypic, Acute1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myelomonocytic, Chronic1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.